Journey Advisory Group LLC Has $489,000 Holdings in Danaher Corporation $DHR

Journey Advisory Group LLC cut its holdings in shares of Danaher Corporation (NYSE:DHR) by 83.1% during the 3rd quarter, Holdings Channel reports. The firm owned 2,465 shares of the conglomerate’s stock after selling 12,079 shares during the period. Journey Advisory Group LLC’s holdings in Danaher were worth $489,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also made changes to their positions in the stock. WFA of San Diego LLC bought a new position in Danaher during the 2nd quarter worth $26,000. Howard Hughes Medical Institute bought a new stake in shares of Danaher during the 2nd quarter valued at $27,000. ANTIPODES PARTNERS Ltd acquired a new stake in shares of Danaher during the 3rd quarter worth $27,000. TruNorth Capital Management LLC bought a new position in shares of Danaher in the third quarter worth $28,000. Finally, Tripletail Wealth Management LLC bought a new position in shares of Danaher in the third quarter worth $31,000. 79.05% of the stock is currently owned by institutional investors.

Danaher Trading Down 0.8%

Shares of Danaher stock opened at $209.56 on Friday. The firm’s 50 day moving average is $226.85 and its 200 day moving average is $215.89. The firm has a market capitalization of $148.02 billion, a PE ratio of 41.58, a price-to-earnings-growth ratio of 2.83 and a beta of 0.91. Danaher Corporation has a 1 year low of $171.00 and a 1 year high of $242.80. The company has a current ratio of 1.87, a quick ratio of 1.51 and a debt-to-equity ratio of 0.35.

Danaher (NYSE:DHR) last issued its earnings results on Tuesday, January 27th. The conglomerate reported $2.23 earnings per share for the quarter, beating analysts’ consensus estimates of $2.14 by $0.09. The firm had revenue of $6.84 billion for the quarter, compared to analyst estimates of $6.79 billion. Danaher had a net margin of 14.71% and a return on equity of 10.81%. The company’s quarterly revenue was up 4.6% on a year-over-year basis. During the same quarter last year, the business posted $2.14 earnings per share. Equities research analysts forecast that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, January 30th. Shareholders of record on Friday, December 26th were issued a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date of this dividend was Friday, December 26th. Danaher’s dividend payout ratio is presently 25.40%.

Insider Transactions at Danaher

In other Danaher news, EVP Gregory M. Milosevich sold 1,320 shares of the stock in a transaction dated Thursday, February 19th. The stock was sold at an average price of $208.01, for a total value of $274,573.20. Following the completion of the transaction, the executive vice president directly owned 5,099 shares in the company, valued at approximately $1,060,642.99. This trade represents a 20.56% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 11.10% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on DHR. Leerink Partners increased their price objective on shares of Danaher from $260.00 to $270.00 and gave the stock an “outperform” rating in a research note on Friday, January 16th. KeyCorp restated an “overweight” rating on shares of Danaher in a research report on Thursday, January 29th. JPMorgan Chase & Co. increased their price target on shares of Danaher from $270.00 to $275.00 and gave the stock an “overweight” rating in a research report on Thursday, January 29th. The Goldman Sachs Group decreased their price objective on shares of Danaher from $270.00 to $265.00 and set a “buy” rating on the stock in a research note on Thursday, January 29th. Finally, Argus set a $265.00 price objective on shares of Danaher in a research report on Wednesday, January 14th. Twenty analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $253.86.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.